Olmesartan structure
|
Common Name | Olmesartan | ||
---|---|---|---|---|
CAS Number | 144689-24-7 | Molecular Weight | 446.502 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 738.3±70.0 °C at 760 mmHg | |
Molecular Formula | C24H26N6O3 | Melting Point | 186-188ºC | |
MSDS | Chinese USA | Flash Point | 400.3±35.7 °C |
Use of OlmesartanOlmesartan is an angiotensin II receptor (AT1R) antagonist used to treat high blood pressure. |
Name | olmesartan |
---|---|
Synonym | More Synonyms |
Description | Olmesartan is an angiotensin II receptor (AT1R) antagonist used to treat high blood pressure. |
---|---|
Related Catalog | |
In Vivo | Repeated dosing of olmesartan (1 mg/kg, 2 mg/kg, p.o.) dose-dependently decreases mean arterial blood pressure (MAP) in SHR without significant influence on body weight and food intake during 10 weeks[1]. Olmesartan (5 mg/kg/d, p.o.) and Hyd treatments lower systolic blood pressure to the same degree in mice. Olmesartan treatment inhibits cardiac hypertrophy, evaluated by echocardiography, heart weight, cross-sectional area of cardiomyocytes, and gene expression. Olmesartan treatment reverses decreased gene expressions of ACE2 and Mas receptor of Ren-Tg mice and inhibits enhanced NADPH oxidase (Nox)4 expression and reactive oxygen species[2]. |
Animal Admin | Seven week-old male spontaneously hypertensive rats (SHR) are divided into five groups and fed a high fat diet (HFD) (60% kcal as fat) ad libitum. SHR are treated with vehicle (1% tragacanth gum solution), telmisartan (1 mg/kg), telmisartan (2 mg/kg), olmesartan (1 mg/kg) or olmesartan (2 mg/kg) once daily by gastric gavage. After more than 4 weeks-treatment, mean arterial blood pressure is measured for 24 h under a conscious state. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 738.3±70.0 °C at 760 mmHg |
Melting Point | 186-188ºC |
Molecular Formula | C24H26N6O3 |
Molecular Weight | 446.502 |
Flash Point | 400.3±35.7 °C |
Exact Mass | 446.206635 |
PSA | 129.81000 |
LogP | 3.72 |
Vapour Pressure | 0.0±2.6 mmHg at 25°C |
Index of Refraction | 1.671 |
Storage condition | -20°C Freezer |
Hazard Codes | Xi |
---|---|
RIDADR | NONH for all modes of transport |
RTECS | NI4014100 |
HS Code | 2921590090 |
HS Code | 2921590090 |
---|---|
Summary | 2921590090. other aromatic polyamines and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Structure-response relationship in electrospray ionization-mass spectrometry of sartans by artificial neural networks.
J. Chromatogr. A. 1438 , 123-32, (2016) Quantitative structure-property relationship (QSPR) methods are based on the hypothesis that changes in the molecular structure are reflected in changes in the observed property of the molecule. Artif... |
|
Synergistic, cytotoxic and apoptotic activities of olmesartan with NF-κB inhibitor against HeLa human cell line.
Toxicol. Mech. Methods 25 , 614-21, (2015) Over expression of renin-angiotensin system (RAS) and nuclear factor-kappaB (NF-κB) has a major role in many cancers. It has been suggested that some angiotensin receptor blockers (ARBs) could reduce ... |
|
Linear mixed-effects model of QTc prolongation for olmesartan medoxomil.
J. Clin. Pharmacol. , doi:10.1002/jcph.572, (2015)
|
4-(2-Hydroxy-2-propanyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylic acid |
Olmesartan Acid |
MFCD00914967 |
Olmesartan |
5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid |
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- |